Edwin R. Parra

15.2k total citations · 1 hit paper
108 papers, 2.8k citations indexed

About

Edwin R. Parra is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Edwin R. Parra has authored 108 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Oncology, 35 papers in Immunology and 29 papers in Molecular Biology. Recurrent topics in Edwin R. Parra's work include Cancer Immunotherapy and Biomarkers (48 papers), Immunotherapy and Immune Responses (23 papers) and Cancer Cells and Metastasis (11 papers). Edwin R. Parra is often cited by papers focused on Cancer Immunotherapy and Biomarkers (48 papers), Immunotherapy and Immune Responses (23 papers) and Cancer Cells and Metastasis (11 papers). Edwin R. Parra collaborates with scholars based in United States, Brazil and United Kingdom. Edwin R. Parra's co-authors include Ignacio I. Wistuba, Don L. Gibbons, Jaime Rodriguez‐Canales, Jing Wang, Carmen Behrens, Lixia Diao, John V. Heymach, Lauren A. Byers, Limo Chen and Barbara Mino and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Edwin R. Parra

101 papers receiving 2.8k citations

Hit Papers

Epithelial–Mesenchymal Transition Is Associated with a Di... 2016 2026 2019 2022 2016 100 200 300

Peers

Edwin R. Parra
Simone Muenst Switzerland
Elizabeth D. Thompson United States
David Gyorki Australia
Elisa A. Rozeman Netherlands
Geoffrey D. Young United States
Simone Muenst Switzerland
Edwin R. Parra
Citations per year, relative to Edwin R. Parra Edwin R. Parra (= 1×) peers Simone Muenst

Countries citing papers authored by Edwin R. Parra

Since Specialization
Citations

This map shows the geographic impact of Edwin R. Parra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin R. Parra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin R. Parra more than expected).

Fields of papers citing papers by Edwin R. Parra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin R. Parra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin R. Parra. The network helps show where Edwin R. Parra may publish in the future.

Co-authorship network of co-authors of Edwin R. Parra

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin R. Parra. A scholar is included among the top collaborators of Edwin R. Parra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin R. Parra. Edwin R. Parra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morris, Van K., Suyu Liu, Kangyu Lin, et al.. (2025). Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal Canal. Clinical Cancer Research. 31(9). 1657–1666. 1 indexed citations
2.
Visal, Tanvi H., Recep Bayraktar, Petra den Hollander, et al.. (2025). Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer. Cancer Research. 85(5). 894–911. 1 indexed citations
3.
Pandurengan, Renganayaki, et al.. (2023). Spatial modelling of the tumor microenvironment from multiplex immunofluorescence images: methods and applications. Frontiers in Immunology. 14. 3 indexed citations
4.
Parra, Edwin R., et al.. (2023). Cellular and Molecular Mechanisms of Liver Fibrosis in Patients with NAFLD. Cancers. 15(11). 2871–2871. 9 indexed citations
5.
Parra, Edwin R., Jiexin Zhang, Mei Jiang, et al.. (2023). Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancer. Nature Communications. 14(1). 2364–2364. 22 indexed citations
6.
Marques‐Piubelli, Mario L., Do H. Kim, L. Jeffrey Medeiros, et al.. (2023). CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti‐CD30 CAR T‐cell therapy. Histopathology. 83(1). 143–148. 10 indexed citations
7.
Morris, Van K., Haifeng Zhu, Xiaoling Li, et al.. (2023). P-230 Biomarkers associated with survival benefit to atezolizumab and bevacizumab for treatment of metastatic anal cancer. Annals of Oncology. 34. S97–S97. 1 indexed citations
8.
Parra, Edwin R.. (2023). "Let us not Forget Macrophages: The Role of M1 and M2 Macrophages in the Human Body". Biomedical Journal of Scientific & Technical Research. 48(1). 1 indexed citations
9.
Deng, Nan, Laura Reyes-Uribe, Edwin R. Parra, et al.. (2023). Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa. Frontiers in Immunology. 14. 1162669–1162669. 3 indexed citations
10.
12.
Sun, Baohua, Caddie Laberiano-Fernández, Ruth Salazar, et al.. (2022). Impact of Region-of-Interest Size on Immune Profiling Using Multiplex Immunofluorescence Tyramide Signal Amplification for Paraffin-Embedded Tumor Tissues. Pathobiology. 90(1). 1–12. 6 indexed citations
13.
Marangoni, Roberta Gonçalves, Benjamin D. Korman, Edwin R. Parra, et al.. (2021). Pathological pulmonary vascular remodeling is induced by type V collagen in a model of scleroderma. Pathology - Research and Practice. 220. 153382–153382. 4 indexed citations
14.
Laberiano-Fernández, Caddie, et al.. (2021). Best Practices for Technical Reproducibility Assessment of Multiplex Immunofluorescence. Frontiers in Molecular Biosciences. 8. 660202–660202. 12 indexed citations
15.
Aung, Phyu P., Edwin R. Parra, Souptik Barua, et al.. (2019). B7-H3 Expression in Merkel Cell Carcinoma–Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density. Clinical Cancer Research. 25(11). 3455–3467. 29 indexed citations
16.
Wistuba, Ignacio I., Edwin R. Parra, & Alejandro Francisco‐Cruz. (2019). MS17.04 Multiplex Immunohistochemistry. Journal of Thoracic Oncology. 14(10). S191–S191.
17.
Behrens, Carmen, Edwin R. Parra, Jaime Rodriguez‐Canales, et al.. (2017). OA19.02 Sex Differences Are Detected in the Profile of Tumor Associated Inflammatory Cells (TAICs) Are Lung Adenocarcinoma. Journal of Thoracic Oncology. 12(1). S318–S318.
18.
Parra, Edwin R., Carmen Behrens, Jaime Rodriguez‐Canales, et al.. (2016). Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients. Clinical Cancer Research. 22(24). 6278–6289. 103 indexed citations
19.
Lou, Yanyan, Lixia Diao, Edwin R. Parra, et al.. (2016). Epithelial–Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma. Clinical Cancer Research. 22(14). 3630–3642. 349 indexed citations breakdown →
20.
Yoshinari, Natalino Hajime, et al.. (2002). Modelo experimental de doenças difusas do tecido conjuntivo (DDTC) induzido por colágeno do tipo V. Revista Brasileira de Reumatologia. 295–305. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026